MedPath

Reducing painful visual examinations of the large intestine in women who are attending in a bowel cancer screening program

Phase 1
Conditions
Many women are experiencing pain under colonoscopy. The present study aims to reduce pain in women undergoing colonoscopy in a bowel cancer screening program in Norway.
Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
Registration Number
EUCTR2016-005090-13-NO
Lead Sponsor
Cancer Registry of Norway
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
420
Inclusion Criteria

All women attending colonoscopy in the Bowel cancer screening in Norway (BCSN) are eligible for the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 250

Exclusion Criteria

Exclusion criteria are identical to those in BCSN: Potential exclusion criteria are: Former open colon/rectum surgery; individuals in chronic need of care; ongoing chemo- or radiotherapy for malignant disease; chronic heart-/lung disease NYHA III-IV; individuals with heart valve implant and lifelong anticoagulation; coronary attack with need for hospitalization within the last 3 months; cerebrovascular event within
the last 3 months; domiciled outside the screening area; in addition allergy to Fentanyl or Rapifen

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath